We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CMAB Biopharma

News List

CMAB Biopharma and Laekna Therapeutics Collaborate contractpharma
September 24, 2020
Enter strategic agreement for LAE005 global development and commercialization partnership.
CMAB Biopharma Resumes Full-Scale Operation contractpharma
March 25, 2020
CMAB Biopharma has reported that its facility in Suzhou, China has now resumed full operation following the coronavirus COVID-19 outbreak.
CMAB Biopharma Resumes Full-Scale Operation Following the Coronavirus Disease 2019 (COVID-19) Outbreak prnasia
March 23, 2020
CMAB Biopharma (Suzhou) Inc. ("CMAB"), has continued to monitor the development of the COVID-19 pandemic and has taken proactive measures to primarily protect the health of our employees worldwide.
CMAB Biopharma raises funds worth $34 M biospectrumasia
April 03, 2018
The funding proceeds will be used to upgrade CMAB’s 2,000L Good Manufacturing Practices (GMP) facilities.